首页 > 市场调查报告书 > 医疗设备

体外诊断

南美洲和中美洲免疫诊断市场预测至 2030 年 - 区域分析 - 按产品（酶联免疫吸附测定、化学发光免疫测定、放射免疫测定等）、临床适应症和最终用户

市场调查报告书

商品编码

1402450

南美洲和中美洲免疫诊断市场预测至 2030 年 - 区域分析 - 按产品（酶联免疫吸附测定、化学发光免疫测定、放射免疫测定等）、临床适应症和最终用户

South & Central America Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), Clinical Indication, and End User

出版日期: 2023年10月27日 | 出版商:

The Insight Partners | 英文 199 Pages | 订单完成后即时交付

价格

简介目录图表

南美洲和中美洲免疫诊断市场预计将从2023年的9.5572亿美元成长到2030年的16.4852亿美元。预计2023年至2030年CAGR为8.1%。

传染病发生率的增加推动了南美洲和中美洲工业机器人市场

由病毒、真菌、细菌、寄生虫或其有毒产物等感染原引起的几种不断增长的传染病的诊断和治疗，免疫诊断测试的处方数量激增，例如补体结合、沉淀测试、凝集测试、线印迹分析、蛋白质印迹分析、酵素免疫分析(EIA) 和免疫萤光测试。

人类免疫缺乏病毒（HIV）仍然是世界范围内的一个主要公共卫生问题。

此外，结核病 (TB)、COVID-19 和其他医院获得性感染 (HAIs) 需要进行免疫诊断测试。

结核病已成为第 13 大死因，也是仅次于 COVID-19 的第二大传染病杀手。 2020 年，全球有 150 万人死于结核病，估计有 1,000 万人受到影响，其中包括 560 万名男性、330 万名女性和 110 万名儿童。

据 Worldometer 称，全球报告了数百万人因 COVID-19 大流行而死亡。它给医疗保健系统带来了压力，并增加了对免疫诊断测试的需求。

诊断在确定合适的医疗方法方面发挥着至关重要的作用。免疫诊断有助于诊断严重影响免疫系统的疾病。因此，传染病盛行率的上升导致对免疫诊断产品的需求激增。

南美洲和中美洲免疫诊断市场概述

根据《2019年世界人口老化》报告，2019年巴西65岁以上人口数为1952.6万人，预计到2050年将达到5202.6万人。老年人口的增加预计将提高该国肝病、糖尿病等疾病的患病率。结肠癌和胰腺癌，因为老年人更容易患这些癌症以及其他慢性疾病，这将随后增加对诊断的需求。细菌和病毒大流行的大规模爆发、对即时诊断的需求不断增加以及技术的快速发展正在进一步推动分子诊断的发展。例如，2020 年 11 月，专注于传染病的领先即时诊断公司 Chembio Diagnostics, Inc. 透露，其子公司 Chembio Diagnostics Brazil Ltda 获得了国家卫生局 (ANVISA) 批准用于 DPP SARS-巴西的CoV-2 抗原测试系统。在巴西，非传染性疾病也构成了严重的健康问题，占死因的 72%，特别是心血管疾病（31.3%）、癌症（16.3%）、糖尿病（5.2%）和慢性呼吸道疾病（5.8%））。因此，癌症、糖尿病和其他慢性疾病病例的不断增加，对免疫诊断的需求激增。

南美洲及中美洲免疫诊断市场收入及 2030 年预测（百万美元）

南美洲和中美洲免疫诊断市场细分

南美洲和中美洲免疫诊断市场分为产品、临床适应症、最终用户和国家。

根据产品，南美洲和中美洲免疫诊断市场分为酵素连结免疫吸附测定（ELISA）、化学发光免疫测定（CLIA）、放射免疫测定（RIA）等。 2023 年，酵素连结免疫吸附测定 (ELISA) 领域在南美洲和中美洲免疫诊断市场中占据最大份额。化学发光免疫分析 (CLIA) 领域进一步细分为维生素 D 分析市场、HIV 检测市场、HIV a/ab 组合分析市场和其他测试。

根据临床适应症，南美洲和中美洲免疫诊断市场分为传染病、肝炎+HIV、内分泌、胃肠道、代谢等。 2023年，传染病领域在南美洲和中美洲免疫诊断市场中占据最大份额。传染病细分为 COVID-19、结核病、莱姆病、感染管理、寨卡病毒、密螺旋体、火炬、麻疹和腮腺炎、水痘带状疱疹病毒和 EB 病毒。内分泌科进一步细分为高血压、生长、糖尿病、甲状腺和生殖内分泌。

根据最终用户，南美洲和中美洲免疫诊断市场分为医院、诊所、诊断实验室、学术和研究机构等。 2023年，医院细分市场在南美洲和中美洲免疫诊断市场中占据最大份额。

根据国家/地区，南美洲和中美洲免疫诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2023年，南美洲和中美洲其他地区在南美洲和中美洲免疫诊断市场中占据最大份额。

雅培实验室；生物梅里埃公司；丹纳赫公司； DiaSorin SpA； F.霍夫曼-拉罗氏有限公司；珀金埃尔默公司；深圳迈瑞生物医疗电子有限公司；西门子医疗保健有限公司；斯瓦尔生命科学公司；和 Thermo Fisher Scientific Inc 是南美洲和中美洲免疫诊断市场上的一些领先公司。

研究范围
Insight Partners 研究报告指南
市场区隔
- 南美洲和中美洲免疫诊断市场 - 按产品
- 南美洲和中美洲免疫诊断市场 - 按临床适应症
- 南美洲和中美洲免疫诊断市场 - 按最终用户划分
- 南美洲和中美洲免疫诊断市场 - 按国家/地区

第 2 章：南美洲和中美洲免疫诊断市场 - 要点

第 3 章：研究方法

覆盖范围
二次研究
初步研究

第 4 章：南美洲和中美洲免疫诊断市场 - 市场模式

概述
南美洲和中美洲 PEST 分析
专家意见

第 5 章：南美洲和中美洲免疫诊断市场 - 主要市场动态

市场驱动因素
- 传染病病率增加
- 床边免疫诊断的使用不断增加
市场限制
- 报销不足的情况
市场机会
- 关键参与者日益关注研发投资和扩张
未来的趋势
- 免疫诊断的技术进步
影响分析

第 6 章：免疫诊断市场 - 南美洲和中美洲分析

南美洲与中美洲免疫诊断市场收入预测与分析

第 7 章：南美洲和中美洲免疫诊断市场分析 - 按产品

概述
南美洲和中美洲免疫诊断市场（按产品），2022 年和 2030 年 (%)
酵素连结免疫吸附测定法 (ELISA)
化学发光免疫分析 (CLIA)
放射免疫分析 (RIA)
其他的

第 8 章：南美洲和中美洲免疫诊断市场分析 - 临床适应症

概述
南美洲和中美洲免疫诊断市场份额（按临床适应症） - 2022 年和 2030 年（%）
传染性疾病：
- 概述
  - 新冠肺炎
  - 结核
  - 莱姆病
  - 感染管理
  - 寨卡病毒
  - 密螺旋体属
  - 火炬
  - 麻疹和腮腺炎
  - VZV
  - EB病毒
肝炎+爱滋病毒：
- 概述
胃肠道
- 概述
代谢紊乱
- 概述
内分泌科
- 概述
- 高血压
  - 概述
- 生长
  - 概述
- 糖尿病
  - 概述
- 甲状腺
  - 概述
- 生殖内分泌学
  - 概述
其他的
- 概述

第 9 章：南美洲和中美洲免疫诊断市场分析 - 最终用户

概述
南美洲和中美洲最终用户免疫诊断市场占有率 - 2022 年和 2030 年 (%)
医院
- 概述
诊所
- 概述
诊断实验室
- 概述
学术及研究机构
- 概述
其他的
- 概述

第 10 章：南美洲和中美洲免疫诊断市场 - 收入和 2030 年预测 - 国家分析

概述

第 11 章：南美洲和中美洲免疫诊断市场 - 产业格局

概述
南美洲和中美洲免疫诊断市场的成长策略
无机成长策略
- 概述
有机成长策略
- 概述

第 12 章：公司简介

Abbott Laboratories
F. Hoffmann-La Roche Ltd
DiaSorin SpA
Danaher Corp
Thermo Fisher Scientific Inc
PerkinElmer Inc
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
bioMerieux SA
Svar Life Science AB
Siemens Healthcare GmbH

第 13 章：附录

关于 Insight Partners
专业术语

简介目录图表

Product Code: BMIRE00027836

The South & Central America immunodiagnostics market is expected to grow from US$ 955.72 million in 2023 to US$ 1,648.52 million by 2030. It is estimated to grow at a CAGR of 8.1% from 2023 to 2030.

Increasing Prevalence of Infectious Diseases Drive South & Central America Industrial Robotics Market

The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are surging number of prescriptions for immunodiagnostics tests, e.g., complement fixation, precipitation tests, agglutination tests, line blot assays, Western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests.

Human immunodeficiency virus (HIV) continues to be a major public health issue worldwide.

Further, tuberculosis (TB), COVID-19, and other hospital-acquired infections (HAIs) require immunodiagnostics tests.

TB has been the 13th leading cause of death and the second-leading infectious killer after COVID-19. In 2020, 1.5 million people died from TB and affected an estimated 10 million people, comprising 5.6 million males, 3.3 million females, and 1.1 million children globally.

According to Worldometer, millions of deaths were reported worldwide due to the COVID-19 pandemic. It strained healthcare systems and increased the need for immunodiagnostics tests.

Diagnostics play a vital role in determining suitable medical treatments. Immunodiagnostics help diagnose diseases that severely impact the immune system. Hence, the rising prevalence of infectious diseases lead to the surging demand for immunodiagnostics products.

South & Central America Immunodiagnostics Market Overview

According to World Population Ageing 2019 report, the number of people aged above 65 years was 19.526 million in Brazil in 2019 and is expected to reach 52.026 million by 2050. This increase in the geriatric population is expected to raise the country's prevalence rate of liver, colon, and pancreatic cancer since older people are more prone to these cancers, as well as other chronic diseases, which would subsequently boost the demand for diagnostics. Large outbreaks of bacterial and viral pandemics, increasing demand for point-of-care diagnostics, and rapidly evolving technology are further propelling the growth of molecular diagnostics. For instance, in November 2020, Chembio Diagnostics, Inc., a leading point-of-care diagnostic company focused on infectious diseases, revealed that its subsidiary Chembio Diagnostics Brazil Ltda received Agencia Nacional de Vigilancia Sanitaria (ANVISA) approval for the DPP SARS-CoV-2 Antigen test system in Brazil. In Brazil, NCDs also constitute a health problem of a large magnitude and account for 72% of causes of death, especially cardiovascular diseases (31.3%), cancer (16.3%), diabetes (5.2%), and chronic respiratory disease (5.8%). Thus, the rising cases of cancer, diabetes, and other chronic diseases is surging the demand for immunodiagnostics.

South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Immunodiagnostics Market Segmentation

The South & Central America immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the South & Central America immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered the largest share in the South & Central America immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.

Based on clinical indication, the South & Central America immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered the largest share in the South & Central America immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.

Based on end user, the South & Central America immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered the largest share in the South & Central America immunodiagnostics market.

Based on country, the South & Central America immunodiagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2023, the Rest of South & Central America segment registered the largest share in the South & Central America immunodiagnostics market.

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America immunodiagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America immunodiagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Immunodiagnostics Market - by Product
- 1.3.2 South & Central America Immunodiagnostics Market - by Clinical Indication
- 1.3.3 South & Central America Immunodiagnostics Market - by End User
- 1.3.4 South & Central America Immunodiagnostics Market - by Country

2. South & Central America Immunodiagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Immunodiagnostics Market - Market Landscape

4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert's Opinion

5. South & Central America Immunodiagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Infectious Diseases
- 5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
- 5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
- 5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
- 5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis

6. Immunodiagnostics Market - South & Central America Analysis

6.1 South & Central America Immunodiagnostics Market Revenue Forecast and Analysis

7. South & Central America Immunodiagnostics Market Analysis - by Product

7.1 Overview
7.2 South & Central America Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
- 7.3.1 Overview
- 7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
- 7.4.1 Overview
- 7.4.2 Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Vitamin D Assay
  - 7.4.3.1 Overview
  - 7.4.3.2 Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 HIV Detection
  - 7.4.4.1 Overview
  - 7.4.4.2 HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 HIV Ag/Ab Combo assay
  - 7.4.5.1 Overview
  - 7.4.5.2 HIV Ag/Ab Combo Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.6 Other Tests
  - 7.4.6.1 Overview
  - 7.4.6.2 Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
- 7.5.1 Overview
- 7.5.2 Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Immunodiagnostics Market Analysis - Clinical Indication

8.1 Overview
8.2 South & Central America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 COVID-19
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 COVID-19: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Tuberculosis
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Lyme
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Infection Management
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Zika
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.6 Treponema
    - 8.3.2.6.1 Overview
    - 8.3.2.6.2 Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.7 TORCH
    - 8.3.2.7.1 Overview
    - 8.3.2.7.2 TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.8 Measles and Mumps
    - 8.3.2.8.1 Overview
    - 8.3.2.8.2 Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.9 VZV
    - 8.3.2.9.1 Overview
    - 8.3.2.9.2 VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.10 EBV
    - 8.3.2.10.1 Overview
    - 8.3.2.10.2 EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
- 8.4.1 Overview
- 8.4.2 Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
- 8.5.1 Overview
- 8.5.2 Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
- 8.6.1 Overview
- 8.6.2 Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
- 8.7.1 Overview
- 8.7.2 Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.3 Hypertension
  - 8.7.3.1 Overview
  - 8.7.3.2 Hypertension: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.4 Growth
  - 8.7.4.1 Overview
  - 8.7.4.2 Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.5 Diabetes
  - 8.7.5.1 Overview
  - 8.7.5.2 Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.6 Thyroid
  - 8.7.6.1 Overview
  - 8.7.6.2 Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.7 Reproductive Endocrinology
  - 8.7.7.1 Overview
  - 8.7.7.2 Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Immunodiagnostics Market Analysis - End User

9.1 Overview
9.2 South & Central America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 Clinics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
- 9.6.1 Overview
- 9.6.2 Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Overview

11. South & Central America Immunodiagnostics Market -Industry Landscape

11.1 Overview
11.2 Growth Strategies in the South & Central America immunodiagnostics market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DiaSorin SpA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Danaher Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 PerkinElmer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 bioMerieux SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Svar Life Science AB
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Brazil Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 2. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of South & Central America Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Recent Inorganic Growth Strategies in the South & Central America immunodiagnostics market
Table 20. Recent Organic Growth Strategies in the South & Central America immunodiagnostics market
Table 21. Glossary of Terms, South & Central America Immunodiagnostics Market

List Of Figures

Figure 1. South & Central America Immunodiagnostics Market Segmentation
Figure 2. South & Central America Immunodiagnostics Market, by Country
Figure 3. South & Central America Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in South & Central America Immunodiagnostics Market
Figure 5. Argentina Expected to Show Remarkable Growth During Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. South & Central America Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. South & Central America Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
Figure 10. South & Central America Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 20. Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 29. VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. South & Central America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 42. Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 43. Clinics: South & Central America Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 44. Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 45. Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 46. Others: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 47. South & Central America Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. South & Central America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 49. Brazil: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 50. Argentina: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. Rest of South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. Growth Strategies in the South & Central America immunodiagnostics market